May 5, 2017 / 10:41 AM / 5 months ago

BRIEF-Immunogen reports Q1 loss per share of $0.20

May 5 (Reuters) - Immunogen Inc:

* Immunogen reports recent progress and first quarter 2017 operating results

* Q1 loss per share $0.20

* Q1 revenue $28.5 million versus $19.7 million

* Q1 revenue view $16.2 million -- Thomson Reuters I/B/E/S

* Q1 earnings per share view $-0.34 -- Thomson Reuters I/B/E/S

* Financial guidance for 2017 remains unchanged from that issued in February 2017

* FY 2017 earnings per share view $-1.42, revenue view $66.2 million -- Thomson Reuters I/B/E/S

* Expects that its current cash plus expected cash revenues will enable company to fund operations into q2 of 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below